0001645113 2026-10-01 2026-10-31 0001645113 1 2026-10-01 2026-10-31 shares iso4217:USD pure 0001645113 NovoCure Limited S-8 S-8 EX-FILING FEES Equity false Ordinary Shares, no par value true 13133749 14.43 189519998.07 0.000087 16488.24 189519998.07 16488.24 0 0 16488.24 <div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(1)    This Registration Statement covers 13,133,749 ordinary shares of NovoCure Limited (the “Registrant”) available for issuance pursuant to awards under the NovoCure Limited Amended and Restated 2024 Omnibus Incentive Plan (the “2024 Plan”).</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(2)    Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional securities of the Registrant that become issuable under the Plan relating to adjustments for changes resulting from a stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration.    </span></div>(3)    Completed pursuant to Rule 457(c) and Rule 457(h) of the Securities Act, based on the average of the high and low prices reported for the Registrant’s ordinary shares on the NASDAQ Global Select Market on October 26, 2026.